# Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks

> **NCT01068600** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 318 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Indacaterol
- **DRUG:** Placebo to indacaterol

## Key facts

- **NCT ID:** NCT01068600
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-06
- **Final completion:** —
- **Target enrollment:** 318 (ACTUAL)
- **Last updated:** 2011-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01068600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01068600, "Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01068600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*